About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
BMC Cancer
›
Top Articles
BMC Cancer
Oncology
,
Biology
,
Genetics
4.8
(top 3%)
Impact Factor
5.2
(top 3%)
extended IF
141
(top 2%)
H-Index
13.5K
authors
13.7K
papers
306.1K
citations
8.2K
citing journals
164.1K
citing authors
Most Cited Articles of BMC Cancer
Title
Year
Citations
Hypoxic enhancement of exosome release by breast cancer cells
2012
645
Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials
2010
444
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
2012
412
Interaction and uptake of exosomes by ovarian cancer cells
2011
411
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
2015
393
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
2012
391
Noninvasive detection of lung cancer by analysis of exhaled breath
2009
389
An electronic application for rapidly calculating Charlson comorbidity score
2004
359
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
2007
357
Worldwide trends in mortality from biliary tract malignancies
2002
357
Imagable 4T1 model for the study of late stage breast cancer
2008
355
The claudin gene family: expression in normal and neoplastic tissues
2006
352
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
2011
336
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
2008
315
Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression
2013
314
Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition
2014
309
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
2008
307
The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer
2013
301
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
2010
299
The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
2010
298
Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000
2002
298
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
2007
287
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
2007
284
Follow-up of patients with curatively resected colorectal cancer: a practice guideline
2003
280
Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials
2007
269
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.